CAR T-cell Therapy in Pediatric ALL: Austin's Story
Learn more about:
- The journey of a pediatric ALL survivor
- Chimeric antigen receptor (CAR) T-cell therapy as a new treatment option
- The impact of clinical trials in the advancement of treatment for blood cancer patients
Please share your feedback so we can create future videos that are helpful to you:
Share your Feedback
Support for this video provided by Novartis Oncology.